Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OrganoClick ABFRA:0CF +6.90%13 Days Sales Outstanding is 70.93 as of Jun. 2026, which is 76% above its 10-year median of 40.31. GuruFocus rates FRA:0CF with a GF Score™ of 13/100 and a GF Value™ of €0.10. The stock has 3 warning signs investors should review. Among 1,589 Chemicals companies, OrganoClick AB ranks worse than 55.13% on this metric.
OrganoClick AB's average Accounts Receivable for the
three
months ended in Jun. 2026 was €1.58 Mil. OrganoClick AB's Revenue for the
three
months ended in Jun. 2026 was €2.03 Mil.
Hence, OrganoClick AB's Days Sales Outstanding for the
three
months ended in Jun. 2026 was 70.93.
The historical rank and industry rank for OrganoClick AB's Days Sales Outstanding or its related term are showing as below:
FRA:0CF'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 29.48 Med: 40.31 Max: 67.42
Current: 67.42
During the past 13 years, OrganoClick AB's highest Days Sales Outstanding was 67.42. The lowest was 29.48. And the median was 40.31.
FRA:0CF's Days Sales Outstanding is ranked worse than 55.13% of 1589
companies
in the Chemicals industry
Industry Median: 63.17
vs FRA:0CF: 67.42
OrganoClick AB's Days Sales Outstanding
declined
from Jun. 2025 (78.88) to Jun. 2026 (70.93).
OrganoClick AB (FRA:0CF) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
OrganoClick AB Days Sales Outstanding Related Terms
OrganoClick AB Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for OrganoClick AB's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:0CF vs LIN, SHW, ECL: Days Sales Outstanding Comparison
For the Specialty Chemicals subindustry, OrganoClick AB's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OrganoClick AB Days Sales Outstanding vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, OrganoClick AB's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where OrganoClick AB's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OrganoClick AB (FRA:0CF) has a Days Sales Outstanding of 70.93 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on OrganoClick AB and its competitors. This is 76% above median its historical median of 40.31. Over the past decade, OrganoClick AB's Days Sales Outstanding has ranged from 29.48 to 67.42. According to the industry distribution chart, OrganoClick AB ranks #876 out of 1589 companies in the Chemicals industry, placing it in the top 55.1%.
Is OrganoClick AB's Days Sales Outstanding too high?
OrganoClick AB's current Days Sales Outstanding of 70.93 is 76% above median its 10-year median of 40.31. Over the past 10 years, this metric has ranged from a low of 29.48 to a high of 67.42. The Chemicals industry median Days Sales Outstanding is 63.17. OrganoClick AB's value of 70.93 is 12.3% above this industry median. Based on the distribution chart, OrganoClick AB ranks #876 out of 1589 companies in the Chemicals industry, which is below the industry midpoint. Overall, OrganoClick AB has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does OrganoClick AB's Days Sales Outstanding compare to LIN and SHW?
According to the Chemicals industry distribution chart, OrganoClick AB ranks #876 out of 1589 companies for Days Sales Outstanding. This places OrganoClick AB in the lower half of its industry. The industry median Days Sales Outstanding is 63.17. OrganoClick AB's value of 70.93 is 12.3% above this benchmark. Historically, OrganoClick AB's own Days Sales Outstanding has ranged from 29.48 to 67.42 over the past decade. While the company's 10-year median is 40.31 vs. the industry median of 63.17, OrganoClick AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Chemicals company?
The median Days Sales Outstanding among Chemicals companies is 63.17, based on 1,589 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. OrganoClick AB's current Days Sales Outstanding of 70.93 is 12.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on OrganoClick AB and its competitors. For the Chemicals industry, the median Days Sales Outstanding is 63.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OrganoClick AB's current Days Sales Outstanding is 70.93, which is 76% above median its own 10-year median of 40.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OrganoClick AB stock overvalued right now?
OrganoClick AB (FRA:0CF) has a current Days Sales Outstanding of 70.93. The stock's GF Value™ is €0.10, compared to a current price of €0.01 — trading 87.6% below its estimated fair value. The current Days Sales Outstanding is 70.93, which is 76% above median its 10-year median of 40.31 and 12.3% above the Chemicals industry median of 63.17. OrganoClick AB's overall GF Score™ is 13/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For OrganoClick AB (FRA:0CF), the current Days Sales Outstanding is 70.93 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is OrganoClick AB (FRA:0CF) Overvalued in 2026?
Based on GuruFocus' analysis, OrganoClick AB stock appears to be undervalued.
The current stock price of €0.01 is trading 87.6% below its estimated GF Value™ of €0.10.
Key valuation signals for FRA:0CF:
Days Sales Outstanding: 70.93 (76% above median its 10-year median of 40.31)
GF Value™: €0.10 vs. price of €0.01 (87.6% below fair value)
Industry Position: 12.3% above the Chemicals median (#876 of 1589)
No single metric tells the full story. See the FRA:0CF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
OrganoClick AB is involved in the chemicals industry. Its product portfolio includes green chemical technologies for creating water repellency, biobased binders for increasing the mechanical strength, and wood treatment products for resistance to fungal degradation and resistance to fire. It operates in four business areas Functional Wood, Green coatings & maintenance products, Nonwoven & technical textile, and Other. The group has a single operating segment.
13GF Score
Get the complete analysis for FRA:0CF
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:0CF has been successfully added to your 
